Category - Executive Moves

Executive Moves

ARS appoints Donn Casale as president

ARS Pharmaceuticals (NASDAQ: SPRY) has appointed Donn Casale as president, effective June 1, 2026, with Richard Lowenthal continuing to lead as CEO. Mr. Casale brings 25 years of biopharmaceutical commercial leadership...

May 13, 2026

Executive Moves

BetterLife appoints Doug Drysdale as executive chairman and director

BetterLife Pharma (CSE: BETR; OTCQB: BETRF; FSE: NPAU) has appointed its current corporate advisor, Doug Drysdale, as executive chairman and director. Mr. Drysdale was formerly CEO of Cybin (NYSE: CYBN) where he led the...

May 13, 2026

Executive Moves

Dr. Kyle Bauser joins Titan Partners as Director, Senior Research Analyst

Investment bank Titan Partners has announced that Kyle Bauser, Ph.D., has been appointed Director, Senior Research Analyst covering healthcare technologies. Dr. Bauser brings more than 12 years of experience in equity...

May 12, 2026

Executive Moves

Lindsay Hamelin joins Restart’s BoD

Restart Life Sciences (CSE: HEAL; FSE: HN30; OTC Pink: NMLSF) has announced the appointment of capital markets veteran, Lindsay Hamelin, as an independent director on its board of directors (BoD), effective immediately...

May 7, 2026

Executive Moves

Nancy Saitta and Leilani Bradford join Planet 13’s BoD

Planet 13 Holdings (CSE: PLTH; OTCQX: PLNH) has announced the appointments of the Honorable Nancy Saitta and Leilani Bradford as independent directors, filling two newly created seats on its board of directors (BoD)...

May 5, 2026

Executive Moves

Eupraxia appoints Dr. Jeymi Tambiah as CMO

Eupraxia Pharmaceuticals (NASDAQ: EPRX; TSX: EPRX) has announced the appointment of Jeymi Tambiah, MB ChB, FRCS, MS, FAPCR, FFPM, as chief medical officer (CMO), and the retirement of the current CMO, Dr. Mark Kowalski...

May 4, 2026

Executive Moves

Piper Sandler adds Dr. Patrick McCormick to healthcare investment banking team

Investment bank, Piper Sandler, has announced the appointment of Patrick McCormick, MD, as a managing director in its healthcare investment banking group. Dr. McCormack will be based in San Francisco and focused on...

April 30, 2026

Executive Moves

Kunal Bhatia joins Strand as CFO

Closely held Strand Therapeutics has announced the appointment of Kunal Bhatia as chief financial officer (CFO). Mr. Bhatia brings 15 years of investment banking experience leading fundraising, business development, and...

April 30, 2026

Executive Moves

Inventiva builds C-suite ahead of Phase 3 MASH readout

Inventiva (Euronext Paris and NASDAQ: IVA) has appointed three new members to its leadership team, including Axel-Sven Malkomes as chief financial officer, Susan Coles as chief legal officer, and Pamela Herbster as...

April 27, 2026

Executive Moves

Orlando Oliveira joins Santhera as CEO

Santhera Pharmaceuticals (SIX: SANN) has appointed Orlando Oliveira as chief executive officer (CEO), succeeding Dario Eklund, effective July 15, 2026. With more than 25 years of global experience across specialty...

April 27, 2026

Category - Executive Moves

Subscribe